Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLLIDE: Ozurdex + Lucentis vs Ozurdex in DME
NCT02684084Phase 4Terminated
- Sponsor
- North Toronto Eye Care Laser and Eye Specialists
- Start
- Nov 2015
- Primary completion
- Nov 2016
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by North Toronto Eye Care Laser and Eye Specialists. Started Nov 2015; status: terminated.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02684084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684084.